Skip to main content
Top
Published in: Digestive Diseases and Sciences 12/2007

01-12-2007 | Original Paper

Rotavirus Causes Hepatic Transaminase Elevation

Authors: Jonathan E. Teitelbaum, Rima Daghistani

Published in: Digestive Diseases and Sciences | Issue 12/2007

Login to get access

Abstract

Rotavirus is one of the leading causes of acute gastroenteritis among children. While clinical complaints are generally intestinal including vomiting and diarrhea, there is evidence to suggest that disease outside the gastrointestinal tract occurs. This study examines the frequency of hepatic transaminase elevation in children with rotavirus gastroenteritis. Patients identified with rotavirus gastroenteritis by stool antigen testing between November 2005 and March 2006 had available serum analyzed for alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase, total bilirubin, direct bilirubin, and creatinine phoshosphokinase (CPK). Chart review was conducted to identify patients with possible liver injury unrelated to rotavirus. Among the 92 patients identified with rotavirus during the study period, 75 had serum specimens available for testing. Fifteen patients (20%) had elevated ALT and AST, including one patient with an increase in AST, ALT, alkaline phosphatase, and total and direct bilirubin. The mean ALT elevation was 56 IU/L (range, 44 to 114 IU/L), and the mean AST elevation was 80 IU/L (range, 57 to 126 IU/L). Fifty-three patients (71%) had an increase in AST alone, and three patients (4%) had an increase in AST and alkaline phosphatase. The mean AST values in these groups were 61 IU/L (range, 42 to 110 IU/L) and 79 IU/L (range, 59 to 96 IU/L), respectively. In conclusion, rotavirus commonly causes elevation of liver transaminases.
Literature
1.
go back to reference Prasad BVV, Chiu W (1994) Structure of rotavirus. Curr Top Microbial Immunol 185:9–29 Prasad BVV, Chiu W (1994) Structure of rotavirus. Curr Top Microbial Immunol 185:9–29
2.
go back to reference Shaw AL, Rothnagel R, Chen D, et al (1993) Three-dimensional visualization of the rotavirus hemagglutinin structure. Cell 74:693–701PubMedCrossRef Shaw AL, Rothnagel R, Chen D, et al (1993) Three-dimensional visualization of the rotavirus hemagglutinin structure. Cell 74:693–701PubMedCrossRef
4.
go back to reference Kapikian AZ, Chanock RM (1990) Rotaviruses. In: Virology. Vol. 2. 2nd ed. Fields BN, Knipe DM, Chanock RM, et al (eds). Raven Press, New York, pp 1353–1404 Kapikian AZ, Chanock RM (1990) Rotaviruses. In: Virology. Vol. 2. 2nd ed. Fields BN, Knipe DM, Chanock RM, et al (eds). Raven Press, New York, pp 1353–1404
5.
go back to reference Glass RI, Lew JF, Gangarosa RE, et al (1991) Estimates of morbidity and mortality rates for diarrheal diseases in American children. J Pediatr 118:S27–S33PubMedCrossRef Glass RI, Lew JF, Gangarosa RE, et al (1991) Estimates of morbidity and mortality rates for diarrheal diseases in American children. J Pediatr 118:S27–S33PubMedCrossRef
6.
go back to reference Ho MS, Glass R I, Pinsky PF, et al (1998) Rotavirus as a cause of diarrheal morbidity and mortality in the United States. J Infect Dis 158:1112–1116 Ho MS, Glass R I, Pinsky PF, et al (1998) Rotavirus as a cause of diarrheal morbidity and mortality in the United States. J Infect Dis 158:1112–1116
7.
go back to reference Kilgore PE, Holman RC, Clarke MJ, Glass RI (1995) Trends of diarrheal disease associated mortality in the U.S. children, 1968 through 1991. JAMA 274:1143–1148PubMedCrossRef Kilgore PE, Holman RC, Clarke MJ, Glass RI (1995) Trends of diarrheal disease associated mortality in the U.S. children, 1968 through 1991. JAMA 274:1143–1148PubMedCrossRef
8.
go back to reference Keidan I, Shif I, Keren G, et al (1992) Rotavirus encephalopathy: evidence of central nervous system involvement during rotavirus infection. Pediatr Infect Dis J 11:773–775PubMedCrossRef Keidan I, Shif I, Keren G, et al (1992) Rotavirus encephalopathy: evidence of central nervous system involvement during rotavirus infection. Pediatr Infect Dis J 11:773–775PubMedCrossRef
9.
go back to reference Wong CJ, Price Z, Bruckner DA (1984) Aseptic meningitis in an infant with rotavirus gastroenteritis. Pediatr Infect Dis J 3:244–246CrossRef Wong CJ, Price Z, Bruckner DA (1984) Aseptic meningitis in an infant with rotavirus gastroenteritis. Pediatr Infect Dis J 3:244–246CrossRef
10.
go back to reference Lewis HM, Parry JV, Davies HA, et al (1996) A year’s experience of the rotavirus syndrome and its association with respiratory illness. Arch Dis Child 141:2365–2374 Lewis HM, Parry JV, Davies HA, et al (1996) A year’s experience of the rotavirus syndrome and its association with respiratory illness. Arch Dis Child 141:2365–2374
11.
go back to reference Santosham M, Yolken RH, Quiroz E, et al (1983) Detection of rotavirus in respiratory secretions of children with pneumonia. J Pediatr 103:58 Santosham M, Yolken RH, Quiroz E, et al (1983) Detection of rotavirus in respiratory secretions of children with pneumonia. J Pediatr 103:58
12.
go back to reference Grimwood K, et al (1988) Serum aspartate aminotransferase levels after rotavirus gastroenteritis. J Pediatr 112:597–600PubMedCrossRef Grimwood K, et al (1988) Serum aspartate aminotransferase levels after rotavirus gastroenteritis. J Pediatr 112:597–600PubMedCrossRef
13.
go back to reference Chiappini E, et al (2005) Viremia is a common finding in immunocompetent children with rotavirus infection. J Med Virol 76:265–267PubMedCrossRef Chiappini E, et al (2005) Viremia is a common finding in immunocompetent children with rotavirus infection. J Med Virol 76:265–267PubMedCrossRef
14.
go back to reference Huang XL, et al (2006) Viremia and extraintestinal involvement after rotavirus infection. Zhejiang Da Xue Bao Yi Xue Ban 35:69–75 Huang XL, et al (2006) Viremia and extraintestinal involvement after rotavirus infection. Zhejiang Da Xue Bao Yi Xue Ban 35:69–75
15.
go back to reference Kovacs A, et al (1986) Serum transaminase elevations in infants with rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 5:873–877PubMedCrossRef Kovacs A, et al (1986) Serum transaminase elevations in infants with rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 5:873–877PubMedCrossRef
16.
go back to reference Fischer TK, et al (2005) Rotavirus antigenemia in patients with acute gastroenteritis. J Infect Dis 192:913–919PubMedCrossRef Fischer TK, et al (2005) Rotavirus antigenemia in patients with acute gastroenteritis. J Infect Dis 192:913–919PubMedCrossRef
17.
go back to reference Schwarz KB, et al (1990) Growth of a group a rotavirus in a human liver cell line. Hepatology 12(4; pt 1):638–643PubMedCrossRef Schwarz KB, et al (1990) Growth of a group a rotavirus in a human liver cell line. Hepatology 12(4; pt 1):638–643PubMedCrossRef
18.
go back to reference Riepenhoff-Talty M, et al (1996) Detection of group C rotavirus in infants with extrahepatic biliary atresia. J Infect Dis 174:8–15PubMed Riepenhoff-Talty M, et al (1996) Detection of group C rotavirus in infants with extrahepatic biliary atresia. J Infect Dis 174:8–15PubMed
Metadata
Title
Rotavirus Causes Hepatic Transaminase Elevation
Authors
Jonathan E. Teitelbaum
Rima Daghistani
Publication date
01-12-2007
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 12/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-007-9743-2

Other articles of this Issue 12/2007

Digestive Diseases and Sciences 12/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.